Stocks Comparison
Caris Life Sciences vs Quest Diagnostics: revenue, profit, margins and growth compared
Caris Life Sciences brought in $812M of revenue in fiscal 2025, Quest Diagnostics $11B in fiscal 2025. Revenue changed by +97.0% at Caris Life Sciences and +11.8% at Quest Diagnostics on the year before, so Caris Life Sciences grew faster. Caris Life Sciences kept -8.4% of its revenue as net profit, Quest Diagnostics 9.0%. Free cash flow was $66.9M at Caris Life Sciences and $1.4B at Quest Diagnostics.
Side by side, latest fiscal year
| CAI | DGX | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $812M | $11B |
| Revenue growth | +97.0% | +11.8% |
| Net income | -$68.1M | $992M |
| Net margin | -8.4% | 9.0% |
| Free cash flow | $66.9M | $1.4B |
| Free cash flow margin | 8.2% | 12.3% |
| Earnings per share (diluted) | -$3.22 | $8.75 |
| Cash | $796.3M | $420M |
| Debt | $378.5M | $5.7B |
| Price to earnings | n/a | 27.0 |
| Market value | $9B | $26.1B |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #161 of 523 · Health care | #43 of 523 · Health care |
Over the years
Questions about Caris Life Sciences and Quest Diagnostics
Which is bigger by revenue, Caris Life Sciences or Quest Diagnostics?
Quest Diagnostics is bigger by revenue: $11B in fiscal 2025, against $812M for Caris Life Sciences in fiscal 2025.
Which keeps more of its revenue as profit, Caris Life Sciences or Quest Diagnostics?
Caris Life Sciences had a net margin of -8.4% in fiscal 2025; Quest Diagnostics had 9.0% in fiscal 2025.
Which grew revenue faster, Caris Life Sciences or Quest Diagnostics?
In their latest fiscal years revenue changed by +97.0% at Caris Life Sciences and +11.8% at Quest Diagnostics.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.